Society of Toxicology 61st Annual Meeting and ToxExpo

March 27-31, 2022

We look forward to connecting with you at the Society of Toxicology Annual Meeting and ToxExpo in San Diego, March 27-31. Whether you connect with us one-on-one at Booth #2204 — or you attend one of our five presentations — we welcome the opportunity to learn about your research needs.

Our human experts are ready to support you with the best human-based solutions for your project. Discover more about our end-to-end portfolio of high-quality human-derived research solutions, including a robust offering of human hepatocytes and liver NPCs, the new human hepatic Tri-Culture Model, and human biospecimens.


Society of Toxicology Exhibitor-Hosted Session: Applications of Primary Human Cells and Cell Models for Safety Testing

March 28, 2022, 9-10 a.m.

Ed LeCluyse, PhD, will be presenting at the LifeSciences sponsored Exhibitor-Hosted Session at SOT.

Marked species differences in physiology and biochemical properties, and ultimately susceptibility to toxicity, drive necessity towards the inclusion of primary human cells and human cell models in safety testing. Dr. LeCluyse will discuss new applications using primary human hepatocytes and thyrocytes as well as our all-human hepatic Tri-Culture model.


An In Vitro Human Thyroid Model to Screen and Classify Thyroid-Disrupting Chemicals with Various Modes of Action

March 28, 2022, 2:30-4:15 p.m.

Eda Rogers, PhD, will present a poster at this year's Society of Toxicology Annual Meeting highlighting her recent work on validating cryopreserved primary human thyrocytes in a 96-well 3D microtissue format as an in vitro model to determine effects of potential thyroid disrupting chemicals. Abstract #3226/Poster #P362.


Application of Activity Scoring System to Analyze Trends in Primary Human Hepatocytes' Donor Genotypes

March 29, 2022, 9-10:45 a.m.

Mary Jane Cunningham, PhD, will present her poster at Society of Toxicology's Annual Meeting where she presents an alternative method of activity scoring to translate donor genotypes into metabolizer response phenotypes. Abstract #3708/Poster #P638.


Characterization of Morphology, Longevity and Functionality in an All-Human Cell Based Tri-Culture System

March 30, 2022, 10:45 a.m.-12:30 p.m.

Jessica Weaver, PhD, is presenting a poster at this years' Society of Toxicology Annual Meeting where she will reveal the latest characterization of LifeNet Health's All-Human Tri-Culture System. This work demonstrates that the Tri-Culture System represents a convenient, stable, and reproducible platform for pharmacological and toxicological applications in drug development and risk assessment. Abstract #4439/Poster #P439.


An In Vitro Tri-Culture System to Assess Compound-Induced Hepatic Clearance of Thyroxine in Humans

March 30, 2022, 10:45 a.m.-12:30 p.m.

Ed LeCluyse, PhD, is presenting a poster at the 2022 Society of Toxicology Annual Meeting which represents the results of a collaborative project between LifeNet Health LifeSciences and Corteva Agriscience where the Tri-Culture Model was shown to be a reliable and reproducible in vitro platform for assessing compound effects on T4 metabolism and clearance. Abstract #4434/Poster #P434.


Meet the Experts at Society of Toxicology's ToxExpo

You will not want to miss the opportunity to connect with one of our scientific experts at this years' SOT meeting. 

Each scientist will be available at booth #2204 during the following Meet the Experts sessions to discuss their recent work in developing the latest all-human innovations including our new Tri-Culture Model, 3D thyroid microtissues, and genotyped hepatocytes.

Monday, March 28

  • 10:15-11:15 a.m.     Eda Rogers, PhD
  • 12:30-1:30 p.m.       Jessica Weaver, PhD & Mary Jane Cunningham, PhD
  •  2:30-3:30 p.m.        Ed LeCluyse, PhD

Tuesday, March 29

  • 10:15-11:15 a.m.     Eda Rogers, PhD & Ed LeCluyse, PhD
  • 12:30-1:30 p.m.       Jessica Weaver, PhD & Mary Jane Cunningham, PhD

Wednesday, March 30

  • 10:15-11:15 a.m.     Eda Rogers, PhD
  • 12:30-1:30 p.m.       Jessica Weaver, PhD & Mary Jane Cunningham, PhD